Imidafenacin

DB09262InvestigationalSmall molecule

Imidafenacin is an antispasmodic with anticholinergic effects used to reduce urinary frequency. It antagonizes muscarinic receptors in the bladder to reduce the frequency of urination in the treatment of overactive bladder.

Chemical structure of Imidafenacin
Mechanism
Curator reviewed · 2 references
Primary indication
Used in the treatment of overactive bladder.Curator reviewed · 8 structured indications
Formula / weight
C20H21N3O · 319.408 g/mol (avg)
Code names
KRP-197 · KRP-1979 · Ono-8025

Resolves to

Clinical / RWD
Structure
InChIKeySQKXYSGRELMAAU-UHFFFAOYSA-NSMILESCC1=NC=CN1CCC(C(N)=O)(C1=CC=CC=C1)C1=CC=CC=C1

What you can answer from here — as of May 07, 2021

3Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
1,236Drug interactionsStructured to mechanism, not free text
Sign in
4Clinical trialsPhase, status and sponsor resolved per trial
Sign in
8Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
9ContraindicationsEach with its own population and attribute set
Sign in
6Marketed productsAcross 3 countries and 4 labellers
Sign in
1ATC codeIncluding every combination product, plus 11 drug categories
Sign in
14+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Imidafenacin, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account